Pain Medicine, Interventional Pain Medicine · Shreveport, LA
NPI
1538130018
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
8731 Park Plaza Dr
Shreveport, LA, 71105
Phone (318) 797-5848
Groups this clinician bills Medicare through
Medicare paid, 2024
$329K
5,970 services
Medicare patients, 2024
686
Average age 72
Drug cost, 2024
$1.3M
25,124 prescriptions
Company payments, 2025
$3,474
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randall P Brewer was code J1010 (injection, methylprednisolone acetate, 1 mg), 960 times for 18 patients. In total Randall P Brewer billed 5,970 services in 95 codes, and Medicare paid $329K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 960 | 18 | $0.10 | $97.91 |
| 99214 Office E&M - Established | Office | 799 | 467 | $89.14 | $71K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 694 | 450 | $12.23 | $8,488 |
| 80307 Drug Tests | Office | 546 | 412 | $59.80 | $33K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 392 | 136 | $38.22 | $15K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 202 | 45 | $0.75 | $152 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 175 | 165 | $153.46 | $27K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 136 | 54 | $30.57 | $4,157 |
| 64493 Nerve Block Injection - Back | Facility | 128 | 72 | $90.88 | $12K |
| 64494 Nerve Block Injection - Back | Facility | 126 | 72 | $51.42 | $6,479 |
| 64483 Nerve Block Injection - Back | Facility | 104 | 80 | $84.55 | $8,794 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 97 | 85 | $200.10 | $19K |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 97 | 85 | $61.67 | $5,982 |
| 99204 Office E&M - New | Office | 96 | 96 | $113.40 | $11K |
| 64484 Nerve Block Injection - Back | Facility | 94 | 73 | $37.95 | $3,567 |
By year: 2022 $350K for 5,109 services; 2023 $312K for 4,621 services; 2024 $329K for 5,970 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 546 | 412 | $59.80 | $33K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 175 | 165 | $153.46 | $27K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 28 | 28 | $241.98 | $6,775 |
Medicare prescription drug claims, 2024
In 2024, the drug Randall P Brewer prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 6,482 prescriptions and refills. In total Randall P Brewer wrote 25,124 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 6,482 | 6,483 | 816 | $135K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,780 | 3,781 | 458 | $113K |
| Gabapentin Generic | 1,945 | 2,253 | 341 | $21K |
| Oxycodone Hcl Generic | 1,224 | 1,225 | 150 | $23K |
| Tramadol Hcl Generic | 1,208 | 1,211 | 230 | $9,046 |
| Morphine Sulfate Er Morphine Sulfate | 1,123 | 1,123 | 126 | $32K |
| Pregabalin Generic | 1,034 | 1,116 | 170 | $23K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 789 | 793 | 192 | $17K |
| Cyclobenzaprine Hcl Generic | 711 | 812 | 157 | $4,603 |
| Tizanidine Hcl Generic | 600 | 762 | 131 | $6,297 |
| Duloxetine Hcl Generic | 521 | 639 | 107 | $7,222 |
| Morphine Sulfate Generic | 447 | 447 | 62 | $12K |
| Baclofen Generic | 400 | 491 | 80 | $4,076 |
| Methadone Hcl Generic | 384 | 384 | 45 | $7,942 |
| Methocarbamol Generic | 367 | 399 | 76 | $3,104 |
Brand drugs: 1,275 claims; generic drugs: 23,849 claims; opioid claims: 16,437.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randall P Brewer $3,474 ($3,474 in general payments such as food, travel and fees) from 15 companies. The largest payer was Saluda Medical Americas, Inc. with $606.
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 11 | $606 |
| Stryker Corporation SYK | 4 | $585 |
| Globus Medical, Inc. GMED | 14 | $513 |
| Boston Scientific Corporation BSX | 19 | $456 |
| Abbott Laboratories ABT | 6 | $360 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 20 | $295 |
| Spinal Simplicity, LLC | 4 | $177 |
| Abbvie Inc. ABBV | 13 | $139 |
| Curonix LLC | 2 | $95.77 |
| Medtronic, Inc. MDT | 4 | $69.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.